Bio Essence (BIOE) Non-Current Assets (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Non-Current Assets of $38.0 in Q1 2026, down 60.82% quarter-over-quarter from $97.0 in Q4 2025, and down 86.13% on a YoY basis from $274.0 in Q1 2025.
Bio Essence (BIOE) Non-Current Assets (2020 - 2026) Analysis & Trends
Bio Essence's Non-Current Assets history runs 7 years deep, the most recent figure standing at $38.0 for Q1 2026.
- In Q1 2026, Non-Current Assets fell 86.13% year-over-year to $38.0; the TTM figure through Mar 2026 stood at $38.0 (changed N/A YoY), while the FY2025 annual figure was $97.0, down 70.78% from the prior year.
- Non-Current Assets was $38.0 for Q1 2026 at Bio Essence, down from $97.0 in the prior quarter.
- In the past five years, Non-Current Assets ranged from a high of $1.8 million in Q3 2023 to a low of $38.0 in Q1 2026.
- Historically, Non-Current Assets has averaged $677552.8 across 5 years, with a median of $208241.0 in 2023.
- The sharpest annual moves came in 2023 and 2025: Non-Current Assets jumped 30.59% in 2023, then tumbled 99.98% in 2025.
- A 5-year view of Non-Current Assets shows it stood at $1.3 million in 2022, then slumped by 84.5% to $208241.0 in 2023, then tumbled by 99.84% to $332.0 in 2024, then tumbled by 70.78% to $97.0 in 2025, then sank by 60.82% to $38.0 in 2026.
- The last three Non-Current Assets figures came in at $38.0 (Q1 2026), $97.0 (Q4 2025), and $156.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 26.33 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 8.68 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 3.84 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 2.47 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 9.64 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 2.90 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 1.22 Bn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.40 Bn |
| 10 | Bio Essence | - | - | 319,353.00 | 38.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.00 |
| Dec 31, 2025 | 97.00 |
| Sep 30, 2025 | 156.00 |
| Jun 30, 2025 | 215.00 |
| Mar 31, 2025 | 274.00 |
| Dec 31, 2024 | 332.00 |
| Sep 30, 2024 | 391.00 |
| Jun 30, 2024 | 1.18 Mn |
| Mar 31, 2024 | 204,487.00 |
| Dec 31, 2023 | 208,241.00 |
| Sep 30, 2023 | 1.82 Mn |
| Jun 30, 2023 | 1.28 Mn |
| Mar 31, 2023 | 1.29 Mn |
| Dec 31, 2022 | 1.34 Mn |
| Sep 30, 2022 | 1.39 Mn |
| Jun 30, 2022 | 1.40 Mn |
| Mar 31, 2022 | 1.40 Mn |
| Dec 31, 2021 | 1.44 Mn |
| Sep 30, 2021 | 1.45 Mn |
| Jun 30, 2021 | 1.44 Mn |